Home
Conditions
Arbovirus Infections

Clinical trial condition

Arbovirus Infections

Explore clinical trials studying Arbovirus Infections. Study availability and eligibility vary by location and protocol.

466 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Arbovirus Infections trial results

Completed

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

NCT00161889

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Neuschwanstein Strasse 5 Augsburg, Germany

Marktplatz 33 Bad Saulgau, Germany

Hauptstrasse 9 Bietigheim-Bissingen, Germany

Salzgasse 11 Calw, Germany

View all 19 locations

View Trial Details

Completed

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

NCT00161863

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Austria

Marktplatz 3 Bad Saulgau, Germany

Solothurner Strasse 2 Heilbronn, Germany

Hauptstraße 240 Kehl, Germany

View Trial Details

Completed

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

NCT00161785

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Hospital in Debica - Zespo Opieki Zdrowotnej w Debicy Dębica, Poland

Szpital Jana Pawla II Oddzial Neuroinfekcji Krakow, Poland

View Trial Details

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

NCT00161772

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Austria

Neuschwansteinstrasse 5 Augsburg, Germany

Marktplatz 3 Bad Saulgau, Germany

Hauptstrasse 9 Bietigheim-Bissingen, Germany

View all 23 locations

View Trial Details

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

NCT00161967

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Upper Austria, Austria

Hauptstrasse 240 Kehl, Germany

Niepubliczny ZOZ Zamość, Poland

View Trial Details

Completed

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

NCT00163540

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: SGS Biopharma Research Unit Stuivenberg Antwerp, Belgium

View Trial Details

Completed

Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease

NCT01502735

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +8 more
Locations: WRAIR, Clinical Trials Center (CTC) Silver Spring, Maryland, United States

View Trial Details

Completed

Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines

NCT00735644

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +24 more
Locations: Alabang, Philippines

Bayanan, Philippines

Buli, Philippines

Cupang, Philippines

View Trial Details

Completed

Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults

NCT00746798

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: Advanced Clinical Research Inst. Anaheim, California, United States

Lynn Health Science Institute Colorado Springs, Colorado, United States

Miami Research South Miami, Florida, United States

Advanced Clinical Research- Idaho Boise, Idaho, United States

View all 15 locations

View Trial Details

Completed

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross

NCT01656174

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +7 more
Locations: Creative Testing Solutions Tempe, Arizona, United States

American Red Cross National Testing Laboratory Charlotte, North Carolina, United States

View Trial Details

Arbovirus Infections

Arbovirus Infections trial results

Related conditions